Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bicycle Therapeutics plc - American Depositary Shares
(NQ:
BCYC
)
3.782
+0.172 (+4.76%)
Delayed Quote
Updated: 3:23 PM EST, Nov 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bicycle Therapeutics plc - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
Next >
9 Health Care Stocks With Whale Alerts In Today's Session
↗
November 16, 2023
Via
Benzinga
Expert Ratings for Bicycle Therapeutics
↗
November 03, 2023
Via
Benzinga
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day
November 02, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
October 30, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Where Bicycle Therapeutics Stands With Analysts
↗
September 07, 2023
Via
Benzinga
Expert Ratings for Bicycle Therapeutics
↗
August 04, 2023
Via
Benzinga
Bicycle Therapeutics's Return On Capital Employed Insights
↗
May 17, 2023
Via
Benzinga
Bicycle Therapeutics PLC (NASDAQ: BCYC) Making Surprising Moves in Friday Session
May 12, 2023
Via
Investor Brand Network
Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder Cancer
October 19, 2023
From
Bicycle Therapeutics
Via
Business Wire
Why Shares of Bicycle Therapeutics Were Rising on Monday
↗
September 11, 2023
The company said it is working with the FDA to structure a phase 2/3 trial for its bladder cancer therapy.
Via
The Motley Fool
Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer
September 11, 2023
From
Bicycle Therapeutics
Via
Business Wire
14 Analysts Have This to Say About Bicycle Therapeutics
↗
May 11, 2023
Via
Benzinga
Recap: Bicycle Therapeutics Q1 Earnings
↗
May 04, 2023
Via
Benzinga
Analyst Ratings for Bicycle Therapeutics
↗
April 18, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
↗
September 12, 2023
Via
Benzinga
Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 05, 2023
From
Bicycle Therapeutics
Via
Business Wire
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 03, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
July 18, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Why Bicycle Therapeutics Stock Raced Ahead Today
↗
July 13, 2023
The company's latest attempt at capital raising seems to be having enviable success.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
July 13, 2023
Via
Benzinga
Stratasys, MillerKnoll, Nikola And Other Big Stocks Moving Higher On Thursday
↗
July 13, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) gained 18% to...
Via
Benzinga
Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares
July 12, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares
July 12, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer
June 23, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in the TD Cowen Radiopharmaceutical Innovation Summit
June 13, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference
May 31, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics and Orano Med Present Preclinical Bicycle® Radio-Conjugate Data at TIDES 2023
May 11, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
May 10, 2023
From
Bayer
Via
Business Wire
Bicycle Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 04, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets
May 04, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
